X4 Pharmaceuticals Balance Sheet Analysis

Assets, liabilities, and stockholders equity in millions USD

Scroll to see more
Balance sheet showing assets, liabilities, and shareholders' equity for X4 Pharmaceuticals, Inc. (XFOR) - Annual data in millions USD
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Current Assets
Cash and Cash Equivalents55.7099.22121.7281.7978.71
Short-Term Investments46.3615.000.000.000.00
Cash & Short-Term Investments102.06114.22121.7281.7978.71
Accounts Receivable1.710.561.150.750.92
Inventory2.820.000.000.000.00
Other Current Assets5.597.305.525.343.42
Total Current Assets112.18122.08128.6887.8883.31
Non-Current Assets
Property, Plant & Equipment (Net)4.846.408.3310.229.20
Long-Term Investments0.780.000.000.000.00
Goodwill17.3517.3517.3517.3527.11
Intangible Assets10.000.000.000.000.00
Other Non-Current Assets1.301.441.231.723.26
Total Non-Current Assets34.2725.1826.9129.300.00
Total Assets146.45147.26155.59117.18122.87
Current Liabilities
Accounts Payable8.628.957.784.283.14
Short-Term Debt2.500.001.320.800.00
Current Portion of Long-Term Debt0.000.001.320.800.00
Accrued Liabilities9.954.6211.447.858.02
Other Current Liabilities21.750.000.590.030.00
Total Current Liabilities32.8822.8622.3214.0211.95
Non-Current Liabilities
Long-Term Debt76.8454.5732.3033.1433.18
Other Non-Current Liabilities14.590.4323.300.830.46
Total Non-Current Liabilities91.4273.3059.2138.740.00
Total Liabilities124.3096.1681.5452.7650.07
Stockholders' Equity
Common Stock0.170.170.120.030.02
Retained Earnings-515.36-477.91-376.74-282.87-194.18
Accumulated Other Comprehensive Income-0.12-0.12-0.12-0.12-0.12
Additional Paid-in Capital537.46528.96450.79347.370.00
Shares Outstanding5.705.584.060.940.00
Total Stockholders' Equity22.1551.1074.0564.4172.80
Total Liabilities & Equity146.45147.26155.59117.180.00